0001140361-15-034627.txt : 20150908 0001140361-15-034627.hdr.sgml : 20150907 20150908194223 ACCESSION NUMBER: 0001140361-15-034627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150903 FILED AS OF DATE: 20150908 DATE AS OF CHANGE: 20150908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Douglas Robert Andrew CENTRAL INDEX KEY: 0001352232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 151097775 MAIL ADDRESS: STREET 1: 21 ATTUNGA ROAD CITY: NEWPORT, NEW SOUTH WALES STATE: C3 ZIP: 2106 4 1 doc1.xml FORM 4 X0306 4 2015-09-03 0 0000943819 RESMED INC RMD 0001352232 Douglas Robert Andrew RESMED INC. 9001 SPECTRUM CENTER BLVD. SAN DIEGO CA 92123 0 1 0 0 President and COO ResMed Inc. ResMed Common Stock 2015-09-03 4 S 0 500 52.00 D 55338.764 I Douglas Family Trust ResMed Common Stock 2015-09-03 4 M 0 5833 19.25 A 61171.764 I Douglas Family Trust ResMed Common Stock 2015-09-03 4 S 0 5833 52.043 D 55338.764 I Douglas Family Trust ResMed Common Stock 75316 D ResMed Common Stock Options 19.25 2015-09-03 4 M 0 5833 0 D 2007-02-03 2016-02-03 ResMed Common Stock 5833 23336 D The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended. Represents date options first became exercisable. This transaction was executed in multiple trades at prices ranging from $52.00 to $52.05. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer. Robert Douglas, President and Chief Operating Officer, ResMed Inc. 2015-09-08